Mazzitelli, M.; Gregori, D.; Sasset, L.; Trevenzoli, M.; Scaglione, V.; Lo Menzo, S.; Marinello, S.; Mengato, D.; Venturini, F.; Tiberio, I.;
et al. Cefiderocol-Based versus Colistin-Based Regimens for Severe Carbapenem-Resistant Acinetobacter baumannii Infections: A Propensity Score-Weighted, Retrospective Cohort Study during the First Two Years of the COVID-19 Pandemic. Microorganisms 2023, 11, 984.
https://doi.org/10.3390/microorganisms11040984
AMA Style
Mazzitelli M, Gregori D, Sasset L, Trevenzoli M, Scaglione V, Lo Menzo S, Marinello S, Mengato D, Venturini F, Tiberio I,
et al. Cefiderocol-Based versus Colistin-Based Regimens for Severe Carbapenem-Resistant Acinetobacter baumannii Infections: A Propensity Score-Weighted, Retrospective Cohort Study during the First Two Years of the COVID-19 Pandemic. Microorganisms. 2023; 11(4):984.
https://doi.org/10.3390/microorganisms11040984
Chicago/Turabian Style
Mazzitelli, Maria, Dario Gregori, Lolita Sasset, Marco Trevenzoli, Vincenzo Scaglione, Sara Lo Menzo, Serena Marinello, Daniele Mengato, Francesca Venturini, Ivo Tiberio,
and et al. 2023. "Cefiderocol-Based versus Colistin-Based Regimens for Severe Carbapenem-Resistant Acinetobacter baumannii Infections: A Propensity Score-Weighted, Retrospective Cohort Study during the First Two Years of the COVID-19 Pandemic" Microorganisms 11, no. 4: 984.
https://doi.org/10.3390/microorganisms11040984
APA Style
Mazzitelli, M., Gregori, D., Sasset, L., Trevenzoli, M., Scaglione, V., Lo Menzo, S., Marinello, S., Mengato, D., Venturini, F., Tiberio, I., Navalesi, P., & Cattelan, A.
(2023). Cefiderocol-Based versus Colistin-Based Regimens for Severe Carbapenem-Resistant Acinetobacter baumannii Infections: A Propensity Score-Weighted, Retrospective Cohort Study during the First Two Years of the COVID-19 Pandemic. Microorganisms, 11(4), 984.
https://doi.org/10.3390/microorganisms11040984
